Back
RBC Quant EmergingMarkets Dividend Leaders ETF USD Vs. NovoCure Industry Stock Comparison
Sell
49
RXD.U.TO
RBC Quant EmergingMarkets Dividend Leaders ETF USD
Last Price:
$15.14
Seasonality Move:
-0.63%
Sell
49
NVCR
NovoCure
Last Price:
$30.18
Seasonality Move:
-3.69%
Sell
49
RBC Quant EmergingMarkets Dividend Leaders ETF USD (RXD.U.TO)
is a Sell
Is RBC Quant EmergingMarkets Dividend Leaders ETF USD a Buy, Sell or Hold?
-
The current RBC Quant EmergingMarkets Dividend Leaders ETF USD [RXD.U.TO] share price is $15.14. The Score for RXD.U.TO is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
RXD.U.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
-
NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RXD.U.TO Stock Price Chart
What is RBC Quant EmergingMarkets Dividend Leaders ETF USD's stock price today?
-
The RBC Quant EmergingMarkets Dividend Leaders ETF USD share price today is $15.14Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXD.U.TO is experiencing slight buying pressure.
NVCR Stock Price Chart
RXD.U.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 40.16 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.99 - 15.31) | Sell |
| Bollinger Bands (100): | (14.73 - 15.85) | Sell |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.94 | Buy |
| Relative Strength Index (14 RSI): | 58.79 | Buy |
| Chaikin Money Flow: | -60501 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.36 - 32.64) | Buy |
| Bollinger Bands (100): | (14.38 - 25.86) | Buy |
RXD.U.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.17 | Sell |
| 20-day SMA: | 15.18 | Sell |
| 50-day SMA: | 15.36 | Sell |
| 200-day SMA: | 14.96 | Buy |
| 8-day EMA: | 15.17 | Sell |
| 20-day EMA: | 15.21 | Sell |
| 50-day EMA: | 15.29 | Sell |
| 200-day EMA: | 14.97 | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.52 | Sell |
| 20-day SMA: | 30.41 | Sell |
| 50-day SMA: | 23.25 | Buy |
| 200-day SMA: | 18.89 | Buy |
| 8-day EMA: | 30.36 | Sell |
| 20-day EMA: | 29.22 | Buy |
| 50-day EMA: | 25.18 | Buy |
| 200-day EMA: | 21.21 | Buy |
RBC Quant EmergingMarkets Dividend Leaders ETF USD Earnings Growth & RXD.U.TO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $0.06 per share.
RBC Quant EmergingMarkets Dividend Leaders ETF USD Technical Analysis
| Dec 12 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 24 | Dec 27 | Dec 30 | Jan 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 16 | 17 | 18 | 19 | 20 | 24 | 27 | 30 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Technical Analysis
| Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||